Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Asthma, Prophylaxis Age: Adult Condition: Who received bronchodilators alone |
Dose: Inhalation – 80 mcg Frequency: twice daily Note: Highest Recommended Dose 160 mcg twice daily |
|
Indication: Asthma, Prophylaxis Age: Adult Condition: Who received inhaled corticosteroids |
Dose: Inhalation – 80 mcg Frequency: twice daily Note: Highest Recommended Dose 320 mcg twice daily |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Asthma, Prophylaxis Age: greater than 12 years Condition: Patients who received bronchodilators alone |
Dose: Inhalation – 80 mcg Frequency: twice daily Note: Highest Recommended Dose 160 mcg twice daily |
|
Indication: Asthma, Prophylaxis Age: greater than 12 years Condition: Patients who received inhaled corticosteroids |
Dose: Inhalation – 80 mcg Frequency: twice daily Note: Highest Recommended Dose 320 mcg twice daily |
Administration
- Shake well before use
- Prime before first use
Side Effect
- Headache (11%)
- Nasopharyngitis (11%)
- Epistaxis (4.9%)
- Ear pain (2.2%)
- Facial edema (3%)
- Urticaria (3%)
- Oral candidiasis (3%)
- Back pain (3%)
- Extremety pain (3%)
- Conjunctivitis (3%)
- Upper respiratory infection (9%)
- Gastroenteritis (3%)
- Sinusitis (3%)
- Headache (3.1-6.6%)
- Epistaxis (2.9-6%)
- Nasopharyngitis (3.7%)
- Nasal discomfort (3.2%)
- Ear pain (2.2%)
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Ketoconazole, Itraconazole, Ritonavir, Nelfinavir, Other potent CYP3A4 inhibitors
|
Increased ciclesonide concentrations
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Status Asthmaticus
|
Not effective for emergency treatment
|
|
Severe Acute Asthma
|
Insufficient for acute attacks
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
The inhaler should be stored below 30°C, protected from direct sunlight and heat. The canister should not be broken, punctured or burnt, even when apparently empty. Keep away from eyes. Keep out of reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.